Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Bobilewicz

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
Materia Medica Polona. Polish Journal of Medicine and Pharmacy|July 1, 1994
Practical usefulness of routinely assessed lipid parametersJ Kotlicka, D Bobilewicz
Medycyna Pracy|January 1, 1982
[Selected indicators of lipid metabolism in screening tests of managerial staffs]M Cianciara, D Bobilewicz, J Kotlicka
Experimental and Clinical Endocrinology & Diabetes : Official Journal, German Society of Endocrinology [And] German Diabetes Association|January 28, 2014
Blood ALDH1 and GST activity in diabetes type 2 and its correlation with glycated hemoglobinJ Giebułtowicz, S Sołobodowska, D Bobilewicz, et al.
Pediatria Polska|July 1, 1996
[Serum C reactive protein as a laboratory indicator of infection in neonates]A Jasińska, D Bobilewicz, U Mach
Polski Merkuriusz Lekarski : Organ Polskiego Towarzystwa Lekarskiego|September 1, 1996
[The pancreolaurinic test in patients with chronic pancreatitis and in patients with perforated acute pancreatitis]Z Wójcik, S Switka, D Bobilewicz, et al.
International Journal of Clinical Pharmacology, Therapy, and Toxicology|August 1, 1985
Changes in plasma high density lipoproteins (HDL) levels after salbutamolR Chazan, W Droszcz, D Bobilewicz, et al.
Polski Tygodnik Lekarski (Warsaw, Poland : 1960)|October 1, 1995
[Transferrin and ferritin as laboratory indices of body iron deposits]D Bobilewicz, E Jabłońska, M Iwanowska, et al.
Annales De Biologie Clinique|January 1, 1982
[Immunological assay of apolipoprotein A-I]M Ayrault-Jarrier, D Bobilewicz, D Pastier, et al.
Polski Tygodnik Lekarski (Warsaw, Poland : 1960)|October 1, 1995
[Evaluation of treating anemia in patients undergoing chronic dialysis with small doses of human recombinant erythropoietin]W Marusza, J Matuszkiewicz-Rowińska, Z Tomik, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Materia Medica Polona. Polish Journal of Medicine and Pharmacy|July 1, 1994
Practical usefulness of routinely assessed lipid parametersJ Kotlicka, D Bobilewicz
Medycyna Pracy|January 1, 1982
[Selected indicators of lipid metabolism in screening tests of managerial staffs]M Cianciara, D Bobilewicz, J Kotlicka
Experimental and Clinical Endocrinology & Diabetes : Official Journal, German Society of Endocrinology [And] German Diabetes Association|January 28, 2014
Blood ALDH1 and GST activity in diabetes type 2 and its correlation with glycated hemoglobinJ Giebułtowicz, S Sołobodowska, D Bobilewicz, et al.
Pediatria Polska|July 1, 1996
[Serum C reactive protein as a laboratory indicator of infection in neonates]A Jasińska, D Bobilewicz, U Mach
Polski Merkuriusz Lekarski : Organ Polskiego Towarzystwa Lekarskiego|September 1, 1996
[The pancreolaurinic test in patients with chronic pancreatitis and in patients with perforated acute pancreatitis]Z Wójcik, S Switka, D Bobilewicz, et al.
International Journal of Clinical Pharmacology, Therapy, and Toxicology|August 1, 1985
Changes in plasma high density lipoproteins (HDL) levels after salbutamolR Chazan, W Droszcz, D Bobilewicz, et al.
Polski Tygodnik Lekarski (Warsaw, Poland : 1960)|October 1, 1995
[Transferrin and ferritin as laboratory indices of body iron deposits]D Bobilewicz, E Jabłońska, M Iwanowska, et al.
Annales De Biologie Clinique|January 1, 1982
[Immunological assay of apolipoprotein A-I]M Ayrault-Jarrier, D Bobilewicz, D Pastier, et al.
Polski Tygodnik Lekarski (Warsaw, Poland : 1960)|October 1, 1995
[Evaluation of treating anemia in patients undergoing chronic dialysis with small doses of human recombinant erythropoietin]W Marusza, J Matuszkiewicz-Rowińska, Z Tomik, et al.
Pageof 1